GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cyp2c65 | affects metabolic processing | ISO | CYP2C9 (Homo sapiens) | 6480464 | CTD | CYP2C9 protein affects the metabolism of Losartan | PMID:20405111 PMID:21321060 | Cyp2c65 | increases hydroxylation | ISO | CYP2C9 (Homo sapiens) | 6480464 | CTD | CYP2C9 protein results in increased hydroxylation of Losartan | PMID:25994031 | Cyp2c65 | increases metabolic processing | ISO | CYP2C9 (Homo sapiens) | 6480464 | CTD | CYP2C9 protein results in increased metabolism of Losartan | PMID:19082874 PMID:19715737 PMID:20716633 | Cyp2c65 | multiple interactions | ISO | CYP2C9 (Homo sapiens) | 6480464 | CTD | CYP2C9 gene mutant form inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Losartan]; Resveratrol inhibits the reaction [CYP2C9 protein results in increased metabolism of Losartan] | PMID:20716633 PMID:25994031 | |
Go Back to source page | Continue to Ontology report |